Search research articles
Contact Us
Filters
Showing results (251-260 of 258) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 258 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 22, 2016
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS)
Angelo Karaboyas, Jarcy Zee, Steven M Brunelli, et al.
Clinical Kidney Journal
|
November 16, 2022
Dysnatremia and risk of bloodstream infection in dialysis patients
Robin H Lo, Kamyar Kalantar-Zadeh, Amy S You, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2022
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin
R Iacovelli, C Ciccarese, M Brunelli, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 1, 2008
A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease
Dawei Xie, Marshall M Joffe, Steven M Brunelli, et al.
BMC Nephrology
|
April 4, 2014
Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis
Mitesh Shah, Arsh K Jain, Steven M Brunelli, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
October 24, 2024
Malformations of Cortical Development: Updated Imaging Review
Julia M Brunelli, Thiago J P Lopes, Isabela S Alves, et al.
Journal of the American Society of Nephrology : JASN
|
April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration
Laura M Dember, Eduardo Lacson, Steven M Brunelli, et al.
ESMO Open
|
December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program
S E Rebuzzi, A Signori, S Buti, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 258) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 258 results.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 22, 2016
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS)
Angelo Karaboyas, Jarcy Zee, Steven M Brunelli, et al.
Clinical Kidney Journal
|
November 16, 2022
Dysnatremia and risk of bloodstream infection in dialysis patients
Robin H Lo, Kamyar Kalantar-Zadeh, Amy S You, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 4, 2022
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin
R Iacovelli, C Ciccarese, M Brunelli, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 1, 2008
A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease
Dawei Xie, Marshall M Joffe, Steven M Brunelli, et al.
BMC Nephrology
|
April 4, 2014
Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis
Mitesh Shah, Arsh K Jain, Steven M Brunelli, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
October 24, 2024
Malformations of Cortical Development: Updated Imaging Review
Julia M Brunelli, Thiago J P Lopes, Isabela S Alves, et al.
Journal of the American Society of Nephrology : JASN
|
April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration
Laura M Dember, Eduardo Lacson, Steven M Brunelli, et al.
ESMO Open
|
December 9, 2022
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program
S E Rebuzzi, A Signori, S Buti, et al.
Page
of 26